Longitudinal assessment of mental health and well-being in patients being treated with medications for opioid use disorder in primary care

•This study examined changes in mental health and well-being in patients on MOUDs.•Initial decreases in depression and anxiety were observed.•No changes in mental health and well-being were maintained at 6 months.•Additional psychosocial treatment is needed to support patients on buprenorphine.